'Neuromorphic Technology' Startup Secures Seed Investment from Korea Investment Accelerator [fnMarketWatch]

[Financial News]  Neuromorphic technology startup Nanoratis has secured seed investment from Korea Investment Accelerator. This investment was made through the recruitment of the 7th cohort of Barun Donghaeng by Korea Investment Accelerator, established by Korea Investment Holdings.
Nanoratis receives investment from Korea Investment Accelerator and is provided with various mentoring and networking opportunities for business advancement over a period of 6 months. The investment amount is undisclosed.
The investment manager at Korea Investment Accelerator stated, "Nanoratis develops neuromorphic chips that mimic the neural networks of the human brain, enabling energy-efficient high-performance AI implementation in various fields from healthcare devices to robotics and IoT. It is expected to rapidly grow as an innovative company in the era of Physical AI."
Neuromorphic technology is a next-generation artificial intelligence technology that processes information by mimicking the structure and operating principles of the human brain, using a completely different approach from traditional digital computing methods. Neuromorphic chips are equipped with numerous components that act as neurons and synapses connected in parallel, allowing for distributed processing of calculations, thus performing complex computations efficiently with low power consumption. This characteristic is particularly suitable for battery-based edge devices, such as healthcare wearables or portable medical devices that require real-time data analysis.
For example, while existing deep learning-based AI chips consume tens of watts of power for a single computation, neuromorphic chips operate below tens of milliwatts and can exhibit energy efficiency tens to hundreds of times higher. Additionally, since the neuromorphic system performs computation and storage in one place, it naturally resolves the 'memory bottleneck problem' that occurs in traditional computers.
Nanoratis is leveraging the strengths of this neuromorphic technology to promote commercialization in fields requiring high-speed, low-power processing, such as biosignal analysis. Notably, they are developing an on-device AI-based analysis device capable of predicting not only blood glucose levels but also lactate, oxygen saturation, inflammation markers, and even dementia-related biomarkers by analyzing human cerebrospinal fluid (body fluid) in real-time. This device is designed to quickly and efficiently analyze neurological patterns through neuron-synapse components and make immediate judgments on-site without communication with external servers.
Thus, neuromorphic technology is emerging as a core technology that serves as the brain of next-generation healthcare, robotics, and IoT devices, beyond simple AI computation chips.
An industry insider added, "As the foundational infrastructure of the Physical AI era, neuromorphic computing enables machines that think and react like humans, heralding a paradigm shift across the industry." 




kakim@fnnews.com Kyung-Ah Kim, Reporter